source
- Nobel-winning optogenetics opens path to experimental therapies for blindness and Alzheimer’sOptogenetics, a technique that uses light to control neurons, earned a 2026 Nobel Prize. Researchers say the method is transforming brain mapping from a simple roadmap to a detailed, three-dimensi…
- Leerink analyst downgrades Bristol Myers over pipeline concernsA Leerink analyst signaled new bearishness on Bristol Myers Squibb, downgrading the company's stock rating. Analyst David Risinger moved the rating from outperform to a lower stance, saying he is…